Contrasting Amedica (AMDA) and St Jude Medical (STJ)

Amedica (NASDAQ: AMDA) and St Jude Medical (NYSE:STJ) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, analyst recommendations, risk, earnings and profitability.

Insider & Institutional Ownership

29.0% of Amedica shares are held by institutional investors. Comparatively, 82.7% of St Jude Medical shares are held by institutional investors. 0.1% of Amedica shares are held by insiders. Comparatively, 4.8% of St Jude Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.


St Jude Medical pays an annual dividend of $1.24 per share. Amedica does not pay a dividend. St Jude Medical pays out 54.4% of its earnings in the form of a dividend. Amedica has raised its dividend for 7 consecutive years.

Valuation and Earnings

This table compares Amedica and St Jude Medical’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Amedica $15.23 million 0.46 -$14.76 million N/A N/A
St Jude Medical N/A N/A N/A $2.28 N/A

St Jude Medical has lower revenue, but higher earnings than Amedica.


This table compares Amedica and St Jude Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Amedica -71.07% -73.86% -36.96%
St Jude Medical 14.14% 19.40% 6.75%

Analyst Recommendations

This is a summary of recent ratings and price targets for Amedica and St Jude Medical, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Amedica 0 2 0 0 2.00
St Jude Medical 0 0 0 0 N/A

Amedica presently has a consensus price target of $60.00, indicating a potential upside of 2,543.17%.


St Jude Medical beats Amedica on 5 of the 8 factors compared between the two stocks.

Amedica Company Profile

Amedica Corporation is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer. It is focused on using its silicon nitride ceramic technology platform to develop, manufacture and sell a range of medical devices. It is also engaged in developing wear- and corrosion-resistant implant components for hip and knee arthroplasty. The Company markets its Valeo family of silicon nitride interbody spinal fusion devices in the United States, Europe and Brazil for use in the cervical and thoracolumbar areas of the spine. In addition to its silicon nitride-based spinal fusion products, it markets a line of non-silicon nitride spinal surgery products, which allows the Company to provide surgeons and hospitals with a solution for spinal procedures. Its Valeo interbody spinal fusion devices include Anterior Lumbar, Posterior Lumbar, Oblique Lumbar, Transforaminal Lumbar, Lateral Lumbar, Cervical and Corpectomy.

St Jude Medical Company Profile

St. Jude Medical, Inc. is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. The Company’s product categories include tachycardia implantable cardioverter defibrillator systems; atrial fibrillation products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems); bradycardia pacemaker systems; vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography imaging products, vascular plugs, heart failure monitoring devices and other vascular accessories); structural heart products (heart valve replacement and repair products and structural heart defect devices); neuromodulation products, and Thoratec products.

Receive News & Ratings for Amedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedica and related companies with's FREE daily email newsletter.

Leave a Reply